Please assess the completion status of the following clinical trial:

Trial Title: Deviating the Esophagus in Atrial Fibrillation Ablation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \>18 - Age \< 80 yr~* Documentation of atrial fibrillation (AF)~* Referred for a first ever ablation procedure for AF (prior ablation of right-sided Typical flutter, or limited left-sided of an accessory pathway are permitted)~* General anesthesia~* All patients must understand and adhere to the requirements of the study and be willing to comply with the post study follow-up requirements.~Exclusion Criteria:~* Any reversible cause of AF (post-surgery, thyroid disorder, etc.)~* INR \> 4.0 at the time of the procedure~* H/o of severe esophageal ulcers, strictures, esophagitis or GERD~* H/o Esophageal Surgery~* Prior surgical or catheter ablation procedure for AF (except right atrial flutter ablation)~* Any evidence of esophageal diverticulum or other structural abnormalities of the esophagus seen during baseline barium esophagogram~* Significant abnormality on Swallowing Impairment Score~* Mental impairment precluding signing consent or completing follow up~* Patients with any other significant uncontrolled or unstable medical condition~* Women who are known to be pregnant or have had a positive β-HCG test 7 days prior to procedure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- esophageal deviation (Type: EXPERIMENTAL): esophageal deviation with IDE device during AF ablation
- temperature monitoring (Type: NO_INTERVENTION): luminal esophageal temperature monitoring, standard temperature monitoring alone

Based on this trial design, predict the completion outcome and termination type (if applicable).